Replies to post #443 on Omeros Corporation (OMER)

[umiak]

I can't give you a %. What I can do is encourage you to consider including
in you pondering the fact that OMER will be participating in this:

https://www.ispytrials.org/collaborate/covid-19-updates. So far narsoplimad is the only monoclonal antibody invited. And news could come from FDA or this event. I encourage you to listen to JBM presentation below:

https://investor.omeros.com/events/event-details/omeros-corporation-39th-annual-jp-morgan-healthcare-conference

[umiak]

I tried to find the link to the new slide deck related to the JPM presentation. Not working out for me right now but found a pertinent
slide here:

https://stocktwits.com/cdm85/message/276377372

Notice under MASP-2 lectin pathway it has Covid -19 as end of P2.
The only way I can understand this is through the experience of the CEO transforming a P2 in Narsoplimad into a P3 do to the overwhelming positive data. If you did not know, Omeros has be continuing to treat very ill Covid patients with promising results.